Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

2008574 citationsJournal Articlegold Open Access

Authors

Marc Rodger · Ottawa Hospital

Susan R. Kahn · McGill University

Philip S. Wells

David R. Anderson

Isabelle Chagnon · Hôpital du Sacré-Cœur de Montréal

Grégoire Le Gal · Université de Bretagne Occidentale

Susan Solymoss · McGill University

Mark Crowther

Abstract

Women with 0 or 1 risk factor may safely discontinue oral anticoagulant therapy after 6 months of therapy following a first unprovoked venous thromboembolism. This criterion does not apply to men.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Diagnosis and Treatment of Venous Diseases Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Canadian Medical Association Journal

Volume 179, Issue 5, pp. 417-426

DOI: 10.1503/cmaj.080493

Field-Weighted Citation Impact: 14.47